PATENTS OFFICE JOURNAL - Irish Patents Office
PATENTS OFFICE JOURNAL - Irish Patents Office
PATENTS OFFICE JOURNAL - Irish Patents Office
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(No. 2056) <strong>Patents</strong> <strong>Office</strong> Journal (04/10/2006)<br />
1140020 Int. Cl. A61K 9/12 (2006.01); A61K 9/127 (2006.01). LARGE MOLECULE<br />
DRUG DELIVERY SYSTEM USING AEROSOLIZED MEMBRANE-<br />
MIMETIC AMPHIPHILES. Generex Pharmaceuticals Inc.<br />
1140028 Int. Cl. A61K 9/16 (2006.01); A61P 35/00 (2006.01). BIODEGRADABLE<br />
POLY(PHOSPHOESTER) COMPOSITIONS FOR TREATING OVARIAN<br />
CANCER. GUILFORD PHARMACEUTICALS INC.<br />
1140043 Int. Cl. A61K 31/00 (2006.01). TRANSGENIC PLANTS COMPRISING A<br />
CONDITIONALLY LETHAL GENE. Dow Agrosciences LLC;NATIONAL<br />
RESEARCH COUNCIL OF CANADA<br />
1140062 Int. Cl. A61K 31/195 (2006.01); A61P 11/06 (2006.01). TREATMENT OF<br />
ASTHMA WITH MEK INHIBITORS. Warner-Lambert Company LLC<br />
1140112 Int. Cl. A61K 31/66 (2006.01); A61P 29/00 (2006.01).<br />
ETHERLYSOPHOSPHOLIPIDS FOR THE TREATMENT OF CHRONIC<br />
INFLAMMATORY DISEASES. INKEYSA, S.A.<br />
1140113 Int. Cl. A61K 31/663 (2006.01); A61P 31/00 (2006.01). USE OF<br />
BISPHOSPHONATES FOR THE PREVENTION AND TREATMENT OF<br />
INFECTIOUS PROCESSES. BioAgency AG<br />
1140114 Int. Cl. A61K 31/675 (2006.01); A61P 31/12 (2006.01); A61K 9/20 (2006.01);<br />
A61K 47/02 (2006.01). PHARMACEUTICAL FORMULATIONS. GILEAD<br />
SCIENCES, INC.<br />
1140135 Int. Cl. A61K 38/13 (2006.01); A61K 9/48 (2006.01); A61K 47/10 (2006.01);<br />
A61K 9/08 (2006.01). CYCLOSPORIN SOLUTION. ratiopharm GmbH<br />
1140187 Int. Cl. A61K 45/06 (2006.01); A61K 31/55 (2006.01); A61K 31/585 (2006.01);<br />
A61P 9/00 (2006.01); A61K 31/575 (2006.01). COMBINATIONS OF AN IBAT<br />
INHIBITOR AND A MTP INHIBITOR FOR CARDIOVASCULAR<br />
INDICATIONS. G.D. Searle LLC.<br />
1140189 Int. Cl. A61K 45/06 (2006.01); A61K 31/55 (2006.01); A61P 9/00 (2006.01).<br />
COMBINATIONS OF ILEAL BILE ACID TRANSPORT INHIBITORS AND<br />
FIBRIC ACID DERIVATIVES FOR CARDIOVASCULAR INDICATIONS.<br />
G.D. Searle LLC.<br />
1140190 Int. Cl. A61K 45/06 (2006.01); A61K 31/785 (2006.01); A61P 9/00 (2006.01).<br />
COMBINATIONS OF ILEAL BILE ACID TRANSPORT INHIBITORS AND<br />
BILE ACID SEQUESTERING AGENTS FOR CARDIOVASCULAR<br />
INDICATIONS. G.D. Searle LLC<br />
1140191 Int. Cl. A61K 45/06 (2006.01); A61K 31/55 (2006.01); A61P 9/00 (2006.01).<br />
COMBINATIONS OF ILEAL BILE ACID TRANSPORT INHIBITORS AND<br />
NICOTINIC ACID DERIVATIVES FOR CARDIOVASCULAR<br />
INDICATIONS. G.D. Searle LLC<br />
2310
Change language